Fei Wang

11.4k total citations · 1 hit paper
313 papers, 6.6k citations indexed

About

Fei Wang is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Fei Wang has authored 313 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Molecular Biology, 115 papers in Cancer Research and 61 papers in Epidemiology. Recurrent topics in Fei Wang's work include Cancer-related molecular mechanisms research (80 papers), MicroRNA in disease regulation (60 papers) and Circular RNAs in diseases (47 papers). Fei Wang is often cited by papers focused on Cancer-related molecular mechanisms research (80 papers), MicroRNA in disease regulation (60 papers) and Circular RNAs in diseases (47 papers). Fei Wang collaborates with scholars based in China, United States and Canada. Fei Wang's co-authors include Jia Xiao, Hua Wang, Kwok‐Fai So, Yingxia Liu, Nai-Kei Wong, Wei Li, Xiaowei Liu, Kazuo Koike, Jiyan Ma and Yin Wu and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Fei Wang

301 papers receiving 6.6k citations

Hit Papers

Global liver disease burdens and research trends: Analysi... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Wang China 41 3.5k 2.4k 1.1k 707 647 313 6.6k
Mohit Kapoor Canada 43 2.9k 0.8× 1.5k 0.6× 518 0.5× 554 0.8× 870 1.3× 144 7.5k
Guo‐Chang Fan United States 55 6.4k 1.9× 2.7k 1.1× 967 0.9× 777 1.1× 1.1k 1.6× 150 9.9k
Qiang Wang China 41 4.9k 1.4× 3.0k 1.2× 732 0.7× 261 0.4× 552 0.9× 287 7.2k
Yong Zhang China 49 5.4k 1.6× 2.9k 1.2× 1.1k 1.0× 379 0.5× 660 1.0× 256 8.6k
Jian Li China 48 5.3k 1.5× 3.3k 1.4× 692 0.6× 325 0.5× 736 1.1× 272 8.2k
Hao Liu China 44 3.2k 0.9× 1.9k 0.8× 688 0.6× 523 0.7× 929 1.4× 321 7.0k
Yan Wang China 47 3.8k 1.1× 2.5k 1.0× 687 0.6× 338 0.5× 872 1.3× 331 8.7k
Bo Wang China 43 4.7k 1.4× 3.2k 1.3× 1.1k 1.0× 331 0.5× 1.1k 1.7× 169 7.9k
Jing Zhang China 50 7.5k 2.2× 3.3k 1.4× 1.0k 1.0× 516 0.7× 520 0.8× 511 11.1k
Ke Chen China 44 4.1k 1.2× 2.1k 0.9× 867 0.8× 215 0.3× 319 0.5× 213 6.6k

Countries citing papers authored by Fei Wang

Since Specialization
Citations

This map shows the geographic impact of Fei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Wang more than expected).

Fields of papers citing papers by Fei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Wang. The network helps show where Fei Wang may publish in the future.

Co-authorship network of co-authors of Fei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Wang. A scholar is included among the top collaborators of Fei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Wang. Fei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Xiaonan, Fei Wang, Yanbin Shen, & Sheng Dai. (2025). CLEVER-1 blockade reprograms TAMs to overcome anti-PD-1 resistance in gastric cancer. Journal for ImmunoTherapy of Cancer. 13(12). e013145–e013145. 1 indexed citations
2.
Zhang, Nan, et al.. (2024). Evaluation of the lncRNA-miRNA-mRNA ceRNA network in lungs of miR-147 −/− mice. Frontiers in Pharmacology. 15. 1335374–1335374. 2 indexed citations
3.
Li, Yahui, Chunyan Li, Chenchen Zhao, et al.. (2024). Coronavirus M protein promotes mitophagy over virophagy by recruiting PDPK1 to phosphorylate SQSTM1 at T138. Nature Communications. 15(1). 8927–8927. 1 indexed citations
5.
Zhao, Yaoyao, et al.. (2024). Comparing the long‐term follow‐up anal function between robot‐assisted and laparoscopic surgery for low rectal cancer: A meta‐analysis and systematic review. International Journal of Medical Robotics and Computer Assisted Surgery. 20(4). e2659–e2659. 2 indexed citations
7.
Dong, Hongliang, Weiwei Chen, Qian Zhang, et al.. (2023). N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness. Cell Death Discovery. 9(1). 149–149. 19 indexed citations
8.
Wang, Fei, et al.. (2023). Purchase intention of Autonomous vehicles and industrial Policies: Evidence from a national survey in China. Transportation Research Part A Policy and Practice. 173. 103719–103719. 13 indexed citations
9.
Wang, Fei, et al.. (2023). LncRNA THRIL Functions as a Marker for Carotid Artery Stenosis and Affects the Biological Function of Human Aortic Endothelial Cell. Journal of Inflammation Research. Volume 16. 2437–2446. 4 indexed citations
10.
Chen, Feng, Zhaodi Che, Yingxia Liu, et al.. (2023). Invigorating human MSCs for transplantation therapy via Nrf2/DKK1 co-stimulation in an acute-on-chronic liver failure mouse model. Gastroenterology report. 12. goae016–goae016. 1 indexed citations
11.
Li, Mingwei, et al.. (2023). Biallelic truncating TTN variants in M‐band encoding exons cause a fetal lethal titinopathy. Prenatal Diagnosis. 44(1). 81–87. 1 indexed citations
12.
Zhang, Xiaobin, et al.. (2023). Identification of novel lncRNA prognostic biomarkers and their associated ceRNAs in bladder urothelial carcinoma. Journal of Biochemical and Molecular Toxicology. 37(10). e23441–e23441. 1 indexed citations
13.
Zhang, Yiming, et al.. (2023). Molecular features and predictive models identify the most lethal subtype and a therapeutic target for osteosarcoma. Frontiers in Oncology. 13. 1111570–1111570. 3 indexed citations
14.
Zhang, Haitian, Guangyan Zhangyuan, Fei Wang, et al.. (2023). A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis. Journal of Hepatology. 79(2). 403–416. 39 indexed citations
16.
Tian, Kai, et al.. (2020). Long Noncoding RNA X-Inactive Specific Transcript Facilitates Cellular Functions in Melanoma via miR-139-5p/ROCK1 Pathway. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Yang, Yang, Xueting Deng, Quanpeng Li, et al.. (2020). Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges. Cancer Communications. 40(12). 655–680. 18 indexed citations
18.
Wang, Fei, et al.. (2020). Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway. SHILAP Revista de lepidopterología. 6 indexed citations
19.
Wang, Fei, Jie Long, Liang Li, et al.. (2020). Mutations in the notch signalling pathway are associated with enhanced anti‐tumour immunity in colorectal cancer. Journal of Cellular and Molecular Medicine. 24(20). 12176–12187. 23 indexed citations
20.
Wei, Jun, Fei Wang, Ling-Yuan Kong, et al.. (2013). miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma. Cancer Research. 73(13). 3913–3926. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026